Haifa, Israel

Gil Moshe Lewitus

This inventor holds 2 USPTO granted patents. Top assignees: Technion Research & Development Foundation Ltd, Tel Aviv University, Other. Active years: 2025-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gil Moshe Lewitus. Retrieved from https://idiyas.com/inventor/gil-moshe-lewitus-lbdg7pqf

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 50.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2025-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Gil Moshe Lewitus: Innovator in Cannabinoid Research

Introduction

Gil Moshe Lewitus is a notable inventor based in Haifa, Israel. He has made significant contributions to the field of cannabinoid research, particularly in the development of pharmaceutical compositions that utilize cannabinoids for therapeutic purposes. His work is particularly focused on treating diseases related to NOTCH 1.

Latest Patents

Lewitus holds a patent titled "Cannabinoids and uses thereof." This invention provides a pharmaceutical composition that includes a combination of at least two cannabinoids. The methods outlined in the patent are aimed at treating NOTCH 1-related diseases, showcasing the potential of cannabinoids in medical applications. He has 1 patent to his name.

Career Highlights

Throughout his career, Lewitus has been associated with prestigious institutions such as Tel Aviv University and the Technion Research & Development Foundation Ltd. His work in these organizations has allowed him to explore innovative solutions in cannabinoid research and development.

Collaborations

Some of his notable coworkers include David Meiri and Elazar Besser. Their collaborative efforts have contributed to advancing the understanding and application of cannabinoids in medicine.

Conclusion

Gil Moshe Lewitus stands out as an influential figure in cannabinoid research, with a focus on developing therapeutic solutions for complex diseases. His contributions continue to pave the way for future innovations in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…